SlideShare ist ein Scribd-Unternehmen logo
1 von 16
1
USFDA
BY
M.SADHANA REDDY
M.Pharm Pharmaceutics & DRA
Krishna Teja Pharmacy College, Tirupati
The Food and Drug Administration (FDA),
established in 1930 as a part of the US Department of
Health and Human Services (DHHS),regulates
products accounting for roughly 25% of the United
States gross national product.
2
The U.S. Food and Drug Administration (FDA) is
an agency of the US Department of Health and
Human Services (DHHS) that is responsible for the
safety regulation of:
◦ most types of foods
◦ drugs
◦ vaccines
◦ blood products
◦ medical devices
◦ dietary supplements
◦ biological medical products
◦ radiation-emitting devices
◦ veterinary products
◦ cosmetics
3
The FDA has its headquarters at White Oak,
Maryland. The agency also has 223 field offices and
13 laboratories located throughout the 50 states,
the United States Virgin Islands, and Puerto Rico.
In 2008, the FDA started opening offices in foreign
countries, including China, India,
CostaRica, Chile, Belgium, and the United Kingdom.
4
5
3. FDA Objective
Better
consumer
information.
Post
marketing
safety
Counter
terrorism
New
product
review
Keep
watch on
safe
manufacturing
and handling
Monitoring
for
new risk
Standard
and
regulation
Enforcement
&
correcting
problem
Center for Veterinary
Devices
Food and Drug
Administration
Center for Biologics
Evaluation and Research
Center for Devices and
Radiological Health
National Center for
Toxicological Research
Center for Food Safety and
Applied Nutrition
Center for Drug Evaluation
and Research
Office of
Combination
Products
6
7
8
What is the need?
The Food and Drug Modernization Act states that
the FDA has 4 goals:
 Goal 1: Strengthen FDA for Today and Tomorrow
 Goal 2: Improve Patient and Consumer Safety
 Goal 3: Increase Access to New Medical and Food Products
 Goal 4: Improve the Quality and Safety of Manufactured
Products and the Supply Chain
9
10
1. Biologics
2. Product and manufacturing establishment licensing
3. Safety of the nation's blood supply
4. Research to establish product standards and develop improved
testing methods
5. Cosmetics
6. Safety
7. Labeling
8. Drugs
9. Product approvals
10. OTC and prescription drug labeling
11. Drug manufacturing standards
11
12. Safety of all food products
13. Medical devices
14. Manufacturing and performance standards
15. Tracking reports of device malfunctioning and serious adverse
reactions
16. Radiation-emitting electronic products
17. Radiation safety performance standards for microwave ovens,
television receivers, diagnostic
18. X-ray equipment, cabinet x-ray systems (such as baggage x-
rays at airports), laser products,
19. Ultrasonic therapy equipment, mercury vapor lamps, and
sunlamps
20. Veterinary products
 advertising (except for prescription drugs, medical
devices, and tobacco products).
 alcoholic beverages
 some consumer products, such as paint, child-
resistant packages, baby toys, and household
appliances (except for those that give off radiation)
 illegal drugs of abuse, such as heroin and marijuana.
 health insurance.
 meat and poultry (except for game meats, such as
venison, ostrich, and snake).
 Restaurants and grocery stores.
Water
12
۩ Investigational New Drug Forms (IND)
 FDA 1571 Investigational New Drug Application
 FDA 1572 Statement of Investigator
 Instructions for completing FDA forms 1571 and 1572.
۩ New Drug Application Forms (NDA)
 Form FDA-356h Application to Market a New Drug,
Biologic, or An Antibiotic Drug For Human Use.
 Form FDA-3331 New Drug Application Field Report
13
Form FDA-356h Application to Market a New
Drug, Biologic or An Antibiotic Drug For
Human Use.
 Guidance for industry: providing regulatory
submissions in electronic format –general
consideration.
۩ Abbreviated New Drug Application Forms
(ANDA) for Generic Drug Products
14
۩ Orphan Drug Products (for rare diseases and
disorders)
There is no form, but there is a prescribed format for
application for orphan drug status. The section from the
regulations that describes the format can be found on
this website on the The Orphan Drug Act and Related
Law and Regulation page.
۩ Electronic Regulatory Submission & Review (ERSR)
 Regulation and Instructions For Submitting Drug
Application Electronic This webpage provides for
information on CDER's program to enable the electronic
submission of regulatory information to the Center and
the review of it by CDER staff.
.
15
16
THANK YOU

Weitere ähnliche Inhalte

Was ist angesagt?

Common Technical Document (CTD)
Common Technical Document (CTD)Common Technical Document (CTD)
Common Technical Document (CTD)Swapnil Fernandes
 
Central drug standard control organisation
Central drug standard control organisationCentral drug standard control organisation
Central drug standard control organisationbdvfgbdhg
 
Introduction to pharmaceutical regulatory agencies
Introduction to pharmaceutical regulatory agenciesIntroduction to pharmaceutical regulatory agencies
Introduction to pharmaceutical regulatory agenciesDoaa Abouzeid
 
central and state Regulatory bodies in India
central and state Regulatory bodies in Indiacentral and state Regulatory bodies in India
central and state Regulatory bodies in Indiasonaliph
 
US - FDA Regulatory Agency Overview.
US - FDA Regulatory Agency Overview.US - FDA Regulatory Agency Overview.
US - FDA Regulatory Agency Overview.Venugopal N
 
ICH: Introduction, objectives & guidelines: A brief insight.
ICH: Introduction, objectives & guidelines: A brief insight.ICH: Introduction, objectives & guidelines: A brief insight.
ICH: Introduction, objectives & guidelines: A brief insight.RxVichuZ
 
Investigational new drug (IND)
Investigational new drug (IND)Investigational new drug (IND)
Investigational new drug (IND)Manish Rajput
 
THERAPEUTIC GOODS ADMINISTRATION (TGA) and MHRA
THERAPEUTIC GOODS ADMINISTRATION (TGA) and MHRATHERAPEUTIC GOODS ADMINISTRATION (TGA) and MHRA
THERAPEUTIC GOODS ADMINISTRATION (TGA) and MHRAManikant Prasad Shah
 
NEW DRUG APPLICATION ( NDA)
NEW DRUG APPLICATION ( NDA)NEW DRUG APPLICATION ( NDA)
NEW DRUG APPLICATION ( NDA)Suvarta Maru
 
Regulatory authorities (US-FDA, WHO and ICH)
Regulatory authorities (US-FDA, WHO and ICH)Regulatory authorities (US-FDA, WHO and ICH)
Regulatory authorities (US-FDA, WHO and ICH)Sagar Savale
 
Regulations for drug approval in USA, E.U & India
Regulations for drug approval in USA, E.U & IndiaRegulations for drug approval in USA, E.U & India
Regulations for drug approval in USA, E.U & IndiaDr. Pankaj Bablani
 
Approval and Application Process involved in Investigational New Drug (IND)
Approval and Application Process involved in Investigational New Drug (IND)Approval and Application Process involved in Investigational New Drug (IND)
Approval and Application Process involved in Investigational New Drug (IND)Nipun Gupta
 
Quality, Safety and Legislation of Herbal Products in India
Quality, Safety and Legislation of Herbal Products in IndiaQuality, Safety and Legislation of Herbal Products in India
Quality, Safety and Legislation of Herbal Products in IndiaS S N D Balakrishna Ch
 
New Drug Application [NDA]
New Drug Application [NDA]New Drug Application [NDA]
New Drug Application [NDA]Sagar Savale
 
2. unit II, chapter-2 regulatory authorities and agencies.
2. unit II, chapter-2 regulatory authorities and agencies.2. unit II, chapter-2 regulatory authorities and agencies.
2. unit II, chapter-2 regulatory authorities and agencies.Audumbar Mali
 
PROCESS OF ICH (International Council for Harmonisation)
PROCESS OF ICH (International Council for Harmonisation)PROCESS OF ICH (International Council for Harmonisation)
PROCESS OF ICH (International Council for Harmonisation)Swathi P
 
Drug Safety & Pharmacovigilance - Introduction - Katalyst HLS
Drug Safety & Pharmacovigilance - Introduction - Katalyst HLSDrug Safety & Pharmacovigilance - Introduction - Katalyst HLS
Drug Safety & Pharmacovigilance - Introduction - Katalyst HLSKatalyst HLS
 
USFDA guidelines of glp for non clinical testing laboratories
USFDA guidelines of glp for non clinical testing laboratoriesUSFDA guidelines of glp for non clinical testing laboratories
USFDA guidelines of glp for non clinical testing laboratoriesswrk
 

Was ist angesagt? (20)

Common Technical Document (CTD)
Common Technical Document (CTD)Common Technical Document (CTD)
Common Technical Document (CTD)
 
Central drug standard control organisation
Central drug standard control organisationCentral drug standard control organisation
Central drug standard control organisation
 
Introduction to pharmaceutical regulatory agencies
Introduction to pharmaceutical regulatory agenciesIntroduction to pharmaceutical regulatory agencies
Introduction to pharmaceutical regulatory agencies
 
central and state Regulatory bodies in India
central and state Regulatory bodies in Indiacentral and state Regulatory bodies in India
central and state Regulatory bodies in India
 
Usfda guidelines (1)
Usfda guidelines (1)Usfda guidelines (1)
Usfda guidelines (1)
 
US - FDA Regulatory Agency Overview.
US - FDA Regulatory Agency Overview.US - FDA Regulatory Agency Overview.
US - FDA Regulatory Agency Overview.
 
ICH: Introduction, objectives & guidelines: A brief insight.
ICH: Introduction, objectives & guidelines: A brief insight.ICH: Introduction, objectives & guidelines: A brief insight.
ICH: Introduction, objectives & guidelines: A brief insight.
 
Investigational new drug (IND)
Investigational new drug (IND)Investigational new drug (IND)
Investigational new drug (IND)
 
THERAPEUTIC GOODS ADMINISTRATION (TGA) and MHRA
THERAPEUTIC GOODS ADMINISTRATION (TGA) and MHRATHERAPEUTIC GOODS ADMINISTRATION (TGA) and MHRA
THERAPEUTIC GOODS ADMINISTRATION (TGA) and MHRA
 
NEW DRUG APPLICATION ( NDA)
NEW DRUG APPLICATION ( NDA)NEW DRUG APPLICATION ( NDA)
NEW DRUG APPLICATION ( NDA)
 
Regulatory authorities (US-FDA, WHO and ICH)
Regulatory authorities (US-FDA, WHO and ICH)Regulatory authorities (US-FDA, WHO and ICH)
Regulatory authorities (US-FDA, WHO and ICH)
 
Regulations for drug approval in USA, E.U & India
Regulations for drug approval in USA, E.U & IndiaRegulations for drug approval in USA, E.U & India
Regulations for drug approval in USA, E.U & India
 
Approval and Application Process involved in Investigational New Drug (IND)
Approval and Application Process involved in Investigational New Drug (IND)Approval and Application Process involved in Investigational New Drug (IND)
Approval and Application Process involved in Investigational New Drug (IND)
 
Quality, Safety and Legislation of Herbal Products in India
Quality, Safety and Legislation of Herbal Products in IndiaQuality, Safety and Legislation of Herbal Products in India
Quality, Safety and Legislation of Herbal Products in India
 
New Drug Application [NDA]
New Drug Application [NDA]New Drug Application [NDA]
New Drug Application [NDA]
 
2. unit II, chapter-2 regulatory authorities and agencies.
2. unit II, chapter-2 regulatory authorities and agencies.2. unit II, chapter-2 regulatory authorities and agencies.
2. unit II, chapter-2 regulatory authorities and agencies.
 
The introduction of an orange book
The introduction of an orange bookThe introduction of an orange book
The introduction of an orange book
 
PROCESS OF ICH (International Council for Harmonisation)
PROCESS OF ICH (International Council for Harmonisation)PROCESS OF ICH (International Council for Harmonisation)
PROCESS OF ICH (International Council for Harmonisation)
 
Drug Safety & Pharmacovigilance - Introduction - Katalyst HLS
Drug Safety & Pharmacovigilance - Introduction - Katalyst HLSDrug Safety & Pharmacovigilance - Introduction - Katalyst HLS
Drug Safety & Pharmacovigilance - Introduction - Katalyst HLS
 
USFDA guidelines of glp for non clinical testing laboratories
USFDA guidelines of glp for non clinical testing laboratoriesUSFDA guidelines of glp for non clinical testing laboratories
USFDA guidelines of glp for non clinical testing laboratories
 

Ähnlich wie Usfda

Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_finalPpt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_finalRajashri Survase Ojha
 
Pharmaceutical regulatory authorities and agencies
Pharmaceutical regulatory authorities and agenciesPharmaceutical regulatory authorities and agencies
Pharmaceutical regulatory authorities and agenciesChintamBaladattaSai
 
FDA- SEMINAR.pptx
FDA- SEMINAR.pptxFDA- SEMINAR.pptx
FDA- SEMINAR.pptxVel Kumar
 
Ind (investigational new drug application) and nda
Ind (investigational new drug application) and ndaInd (investigational new drug application) and nda
Ind (investigational new drug application) and ndaswati2084
 
Pharma Uptoday Monthly Magazine Volume 5, Issue Aug 2014
Pharma Uptoday Monthly Magazine Volume 5, Issue Aug 2014Pharma Uptoday Monthly Magazine Volume 5, Issue Aug 2014
Pharma Uptoday Monthly Magazine Volume 5, Issue Aug 2014Sathish Vemula
 
Regulatory authorities of copyright liasion
Regulatory authorities of copyright liasionRegulatory authorities of copyright liasion
Regulatory authorities of copyright liasionRAMZAHASHMI
 
Regulatory affair - Introduction
Regulatory affair - IntroductionRegulatory affair - Introduction
Regulatory affair - IntroductionDr. Jigar Vyas
 
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptx
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptxMRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptx
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptxDimple Marathe
 
Fundamental concept of regulatory affairs in pharmaceutical & biotechnology
Fundamental concept of regulatory affairs in pharmaceutical & biotechnologyFundamental concept of regulatory affairs in pharmaceutical & biotechnology
Fundamental concept of regulatory affairs in pharmaceutical & biotechnologyHitendra Singh
 

Ähnlich wie Usfda (20)

Usfda swatee
Usfda swateeUsfda swatee
Usfda swatee
 
Madhu k s
Madhu k s Madhu k s
Madhu k s
 
What is FDA?
What is FDA?What is FDA?
What is FDA?
 
Roshan (1)
Roshan (1)Roshan (1)
Roshan (1)
 
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_finalPpt 1 overview of regulatory affairs and diff bodies_august2016_final
Ppt 1 overview of regulatory affairs and diff bodies_august2016_final
 
USFDA Over View
USFDA  Over ViewUSFDA  Over View
USFDA Over View
 
Pharmaceutical regulatory authorities and agencies
Pharmaceutical regulatory authorities and agenciesPharmaceutical regulatory authorities and agencies
Pharmaceutical regulatory authorities and agencies
 
Usfda ppn
Usfda ppnUsfda ppn
Usfda ppn
 
Usfda sana 1
Usfda sana 1Usfda sana 1
Usfda sana 1
 
FDA
FDAFDA
FDA
 
FDA- SEMINAR.pptx
FDA- SEMINAR.pptxFDA- SEMINAR.pptx
FDA- SEMINAR.pptx
 
Ind (investigational new drug application) and nda
Ind (investigational new drug application) and ndaInd (investigational new drug application) and nda
Ind (investigational new drug application) and nda
 
Usfda
Usfda Usfda
Usfda
 
Pharma Uptoday Monthly Magazine Volume 5, Issue Aug 2014
Pharma Uptoday Monthly Magazine Volume 5, Issue Aug 2014Pharma Uptoday Monthly Magazine Volume 5, Issue Aug 2014
Pharma Uptoday Monthly Magazine Volume 5, Issue Aug 2014
 
Drug Regulatory Affairs (DRA)
Drug Regulatory Affairs (DRA)Drug Regulatory Affairs (DRA)
Drug Regulatory Affairs (DRA)
 
Industry and fda laision &
Industry and fda laision &Industry and fda laision &
Industry and fda laision &
 
Regulatory authorities of copyright liasion
Regulatory authorities of copyright liasionRegulatory authorities of copyright liasion
Regulatory authorities of copyright liasion
 
Regulatory affair - Introduction
Regulatory affair - IntroductionRegulatory affair - Introduction
Regulatory affair - Introduction
 
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptx
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptxMRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptx
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptx
 
Fundamental concept of regulatory affairs in pharmaceutical & biotechnology
Fundamental concept of regulatory affairs in pharmaceutical & biotechnologyFundamental concept of regulatory affairs in pharmaceutical & biotechnology
Fundamental concept of regulatory affairs in pharmaceutical & biotechnology
 

Kürzlich hochgeladen

Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxDenish Jangid
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfSanaAli374401
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Shubhangi Sonawane
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introductionMaksud Ahmed
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.pptRamjanShidvankar
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.christianmathematics
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhikauryashika82
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterMateoGardella
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin ClassesCeline George
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingTeacherCyreneCayanan
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 

Kürzlich hochgeladen (20)

Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
An Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdfAn Overview of Mutual Funds Bcom Project.pdf
An Overview of Mutual Funds Bcom Project.pdf
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
microwave assisted reaction. General introduction
microwave assisted reaction. General introductionmicrowave assisted reaction. General introduction
microwave assisted reaction. General introduction
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 

Usfda

  • 1. 1 USFDA BY M.SADHANA REDDY M.Pharm Pharmaceutics & DRA Krishna Teja Pharmacy College, Tirupati
  • 2. The Food and Drug Administration (FDA), established in 1930 as a part of the US Department of Health and Human Services (DHHS),regulates products accounting for roughly 25% of the United States gross national product. 2
  • 3. The U.S. Food and Drug Administration (FDA) is an agency of the US Department of Health and Human Services (DHHS) that is responsible for the safety regulation of: ◦ most types of foods ◦ drugs ◦ vaccines ◦ blood products ◦ medical devices ◦ dietary supplements ◦ biological medical products ◦ radiation-emitting devices ◦ veterinary products ◦ cosmetics 3
  • 4. The FDA has its headquarters at White Oak, Maryland. The agency also has 223 field offices and 13 laboratories located throughout the 50 states, the United States Virgin Islands, and Puerto Rico. In 2008, the FDA started opening offices in foreign countries, including China, India, CostaRica, Chile, Belgium, and the United Kingdom. 4
  • 5. 5 3. FDA Objective Better consumer information. Post marketing safety Counter terrorism New product review Keep watch on safe manufacturing and handling Monitoring for new risk Standard and regulation Enforcement & correcting problem
  • 6. Center for Veterinary Devices Food and Drug Administration Center for Biologics Evaluation and Research Center for Devices and Radiological Health National Center for Toxicological Research Center for Food Safety and Applied Nutrition Center for Drug Evaluation and Research Office of Combination Products 6
  • 7. 7
  • 9. The Food and Drug Modernization Act states that the FDA has 4 goals:  Goal 1: Strengthen FDA for Today and Tomorrow  Goal 2: Improve Patient and Consumer Safety  Goal 3: Increase Access to New Medical and Food Products  Goal 4: Improve the Quality and Safety of Manufactured Products and the Supply Chain 9
  • 10. 10 1. Biologics 2. Product and manufacturing establishment licensing 3. Safety of the nation's blood supply 4. Research to establish product standards and develop improved testing methods 5. Cosmetics 6. Safety 7. Labeling 8. Drugs 9. Product approvals 10. OTC and prescription drug labeling 11. Drug manufacturing standards
  • 11. 11 12. Safety of all food products 13. Medical devices 14. Manufacturing and performance standards 15. Tracking reports of device malfunctioning and serious adverse reactions 16. Radiation-emitting electronic products 17. Radiation safety performance standards for microwave ovens, television receivers, diagnostic 18. X-ray equipment, cabinet x-ray systems (such as baggage x- rays at airports), laser products, 19. Ultrasonic therapy equipment, mercury vapor lamps, and sunlamps 20. Veterinary products
  • 12.  advertising (except for prescription drugs, medical devices, and tobacco products).  alcoholic beverages  some consumer products, such as paint, child- resistant packages, baby toys, and household appliances (except for those that give off radiation)  illegal drugs of abuse, such as heroin and marijuana.  health insurance.  meat and poultry (except for game meats, such as venison, ostrich, and snake).  Restaurants and grocery stores. Water 12
  • 13. ۩ Investigational New Drug Forms (IND)  FDA 1571 Investigational New Drug Application  FDA 1572 Statement of Investigator  Instructions for completing FDA forms 1571 and 1572. ۩ New Drug Application Forms (NDA)  Form FDA-356h Application to Market a New Drug, Biologic, or An Antibiotic Drug For Human Use.  Form FDA-3331 New Drug Application Field Report 13
  • 14. Form FDA-356h Application to Market a New Drug, Biologic or An Antibiotic Drug For Human Use.  Guidance for industry: providing regulatory submissions in electronic format –general consideration. ۩ Abbreviated New Drug Application Forms (ANDA) for Generic Drug Products 14
  • 15. ۩ Orphan Drug Products (for rare diseases and disorders) There is no form, but there is a prescribed format for application for orphan drug status. The section from the regulations that describes the format can be found on this website on the The Orphan Drug Act and Related Law and Regulation page. ۩ Electronic Regulatory Submission & Review (ERSR)  Regulation and Instructions For Submitting Drug Application Electronic This webpage provides for information on CDER's program to enable the electronic submission of regulatory information to the Center and the review of it by CDER staff. . 15